Reference39 articles.
1. Ries LAG, Hankey BF, Miler BA, et al. Cancer Statistics review 1973–88. NIH Publication No. 91-2789. National Cancer Institute, Bethesda, Maryland, 1991.
2. Bladé J, Lopez-Guillermo A, Rozman C, et al. Malignant transformation and life expectancy in monoclonal gammopathy of undetermined significance. Br J Haematol 1992, 81, 391–394.
3. Benign monoclonal gammopathy—after 20 to 35 years of follow-up;Kyle;Mayo Clin Proc,1993
4. Bataille R, Jourdan M, Zhang XG, et al. Serum levels of interleukin-6, a potent myeloma cell growth factor, as a reflect of disease severity in plasma cell dyscrasias. J Clin Invest 1989, 84, 2008–2011.
5. Durie BGM, Salmon SND, Finley SE, et al. Prognostic value of pretreatment serum β2 microglobulin in myeloma, a South-West Oncology Group study. Blood 1990, 75, 823–830.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献